Mark Mallon - Chief Executive Officer, Director at NEOGENOMICS INC

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
NEO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Mark Mallon since 05 Jun 2025

Reported holdings for Mark Mallon in NEOGENOMICS INC

Form 4 holding Chief Executive Officer, Director

NEOGENOMICS INC

Security class
Common Stock
Shares / value
368,051
Estimated value
$6,768,458
Report date
01 Mar 2022
Price
$18.39
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

NEOGENOMICS INC

Security class
Stock Option (Right to Buy)
Shares / value
347,777
Estimated value
Report date
01 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
151,016

Transaction history for Mark Mallon in NEOGENOMICS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .